State-dependent blockade of haloperidol-induced sensitization of catalepsy by MK-801

European Journal of Neuroscience

Volumn 11, Issue 9, 1999, Pages 3365-3368

  Schmidt, Werner J ^a   Tzschentke, Thomas M ^a   Kretschmer, Beate D ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Conditioning; Context; Locomotion; Parkinson's disease; Rat; Sensitization

Indexed keywords

DIZOCILPINE; HALOPERIDOL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CATALEPSY; CONTROLLED STUDY; DRUG SENSITIZATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT;

EID: 0032845088     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9568.1999.00794.x     Document Type: Article

References (20)

1. Blanchet, P.J., Stella, M., Papa, S.M., Verhagen Metman, L., Mouradian, M.M. & Chase, T.N. (1997) Modulation of levodopa-induced motor response complications by NMDA antagonists in Parkinson's disease. Neurosci. Biobehav. Rev., 21, 447-153.
2. Browman, K.E., Badiani, A. & Robinson, T.E. (1998) Modulatory effect of environmental stimuli on the susceptibility to amphetamine sensitization: a dose-effect study in rats. J. Pharmacol. Exp. Ther., 287, 1007-1014.
3. Carlezon, W.A., Mendrek, A. & Wise, R.A. (1995) MK-801 disrupts the expression but not the development of bromocriptine sensitization: a state-dependency interpretation. Synapse, 20, 1-9.
4. Danyelczyk, W. (1995) Twenty-five years of amantadine therapy in Parkinson's disease. J. Neural. Transm., 46, 399-405.
5. France, C.P., Moerschbacher, J.M. & Woods, J.H. (1991) MK-801 and related compounds in monkeys: Discriminative stimulus effects and effects on a conditional discrimination. J. Pharmacol. Exp. Ther., 257, 727-734.
6. Jackson, A., Koek, W. & Colpaert, F.C. (1992) NMDA antagonists make learning and recall state-dependent. Behav. Pharmacol., 3, 415-421.
7. Kalivas, P.W. (1995) Interactions between dopamine and excitatory amino acids in behavioral sensitization to psychostimulants. Drug Alcohol Depend., 37, 95-100.
8. Klemm, W.R. (1989) Drug effects on active immobility responses: What they tell us about neurotransmitter systems and motor functions. Prog. Neurobiol., 32, 403-422.
9. Kornhuber, J., Weller, M. & Riederer, P. (1993) Glutamate receptor antagonists for neuroleptic malignant syndrome and akinetic hyperthermic parkinsonian crisis. J. Neural Transm., 6, 63-72.
10. Kretschmer, B.D. & Fink, S. (1999) Spatial learning deficit after NMDA receptor blockade and state-dependency. Behav. Pharmacol., 10, 412-428.
11. Robinson, T.E. & Becker, J.B. (1986) Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res., 396, 157-198.
12. Robinson, T.E. & Berridge, K.C. (1993) The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain. Res. Rev., 18, 247-291.
13. Sanberg, P.R., Bunsey, M.D., Giordano, M. & Norman, A.B. (1988) The catalepsy test: Its ups and downs. Behav. Neurosci., 102, 748-759.
14. Schmidt, W.J. & Bubser, M. (1988) Anticataleptic effects of the N-methyl-D-aspartate antagonist MK-801 in rats. Pharmacol. Biochem. Behav., 32, 621-623.
15. Stewart, J. & Badiani, A. (1993) Tolerance and sensitization to the behavioral effects of drugs. Behav. Pharmacol., 4, 289-312.
16. Tzschentke, T.M. & Schmidt, W.J. (1996) Procedural examination of behavioural sensitisation to morphine: Lack of blockade by MK-801, occurrence of sensitised sniffing, and evidence for cross-sensitisation between morphine and MK-801. Behav. Pharmacol., 7, 169-184.
17. Tzschentke, T.M. & Schmidt, W.J. (1997) Interactions of MK-801 and GYKI 52466 with morphine and amphetamine in place preference conditioning and behavioural sensitization. Behav. Brain Res., 84, 99-107.
18. Tzschentke, T.M. & Schmidt, W.J. (1998) Does the noncompetitive NMDA receptor antagonist dizocilpine (MK-801) really block behavioural sensitization associated with repeated drug administration? Trends Pharmacol. Sci., 19, 447-451.
19. Verhagen-Metman, L., Del Dotto, P., Blanchet, PJ.., van den Munckhof, P. & Chase, T.N. (1998) Blockade of glutamatergic transmission as treatment for dyskinesias and motor fluctuations in Parkinson's disease. Amino Acids, 14, 75-82.
20. Wolf, M.E. (1998) The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog. Neurobiol., 54, 679-720.